SAB Biotherapeutics (SABS) Notes Payables (2020 - 2025)
SAB Biotherapeutics (SABS) posted Notes Payables of $138,554 for Q1 2025, down 83.4% from $835,467 a year earlier and down 49.8% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Notes Payables (2020 - 2025) Analysis & Trends
At the end of FY2024, SAB Biotherapeutics' Notes Payables came in at $275,849, down 73.7% from FY2023.
- Annual Notes Payables shows a four-year compound annual growth rate of -15.4% (FY2020 to FY2024).
- In prior years, SAB Biotherapeutics' Notes Payables was $1.05 million in FY2023 (+36.0%), $772,665 in FY2022 (-57.0%), $1.8 million in FY2021 (+233.5%) and $538,731 in FY2020.
- The Q1 2025 figure stands as the lowest quarterly Notes Payables since Q2 2023.
- On a year-over-year basis, Notes Payables increased in three of the last six quarters, with growth averaging 59.6%.
- The strongest year-over-year quarter for Notes Payables in the past five years was Q2 2024, with growth of 450.4%; the weakest was Q1 2025, with a decline of 83.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | SAB Biotherapeutics | 279.79 Mn | -130.87 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 138,554.00 |
| Dec 31, 2024 | 275,849.00 |
| Jun 30, 2024 | 615,818.00 |
| Mar 31, 2024 | 835,467.00 |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 541,644.00 |
| Jun 30, 2023 | 111,894.00 |
| Mar 31, 2023 | 444,478.00 |
| Dec 31, 2022 | 772,665.00 |
| Sep 30, 2022 | 25,013.00 |
| Jun 30, 2022 | 278,441.00 |
| Mar 31, 2022 | 1.04 Mn |
| Dec 31, 2021 | 1.80 Mn |
| Dec 31, 2020 | 538,731.00 |
API Access
SAB Biotherapeutics Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();